1/2/2014

The American Heart Association issued a scientific statement on the prevention and treatment of thrombosis in children and adults with congenital heart disease and children with acquired heart disease in a bid to spark research into the risk factors, prevention and treatment of the condition. "Because central venous lines are not without risk, especially in the neonate who has limited access sites, the nurse can be a valuable member of the team in terms of maintaining patency of the line and identifying contraindications for thrombolytic therapy such as the presence of abnormal clotting studies, presence of active bleeding or major surgery within the last 10 days," according to the document.

Related Summaries